Gleevec Market by Product and End User- Global Industry Analysis & Forecast to 2027
Published On : August 2019 Pages : 180 Category: Pharma & Healthcare Report Code : HC085197
Gleevec Market by Product (100mg, 400mg) End User (Hospital, Pharmacy) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The gleevec market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Gleevec is the trade name for the nonexclusive medication name Imatinib Mesylate.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global gleevec market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Novartis
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Gleevec Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o 100mg
o 400mg
o Gleevec Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Hospital
o Pharmacy
o Gleevec Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Novartis
o Gleevec Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Gleevec Market , By Country
o U.S. Gleevec Market
o Canada Gleevec Market
o Mexico Gleevec Market
o Europe
§ Europe Gleevec Market , By Country
o Germany Gleevec Market
o UK Gleevec Market
o France Gleevec Market
o Russia Gleevec Market
o Italy Gleevec Market
o Rest of Europe Gleevec Market
o Asia-Pacific
§ Asia-Pacific Gleevec Market , By Country
o China Gleevec Market
o Japan Gleevec Market
o South Korea Gleevec Market
o India Gleevec Market
o Southeast Asia Gleevec Market
o Rest of Asia-Pacific Gleevec Market
o South America
§ South America Gleevec Market , By Country
o Brazil Gleevec Market
o Argentina Gleevec Market
o Columbia Gleevec Market
o Rest of South America Gleevec Market
o Middle East and Africa
§ Middle East and Africa Gleevec Market , By Country
o Saudi Arabia Gleevec Market
o UAE Gleevec Market
o Egypt Gleevec Market
o Nigeria Gleevec Market
o South Africa Gleevec Market
o Rest of MEA Gleevec Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Gleevec Market, By Product
5.1. Introduction
5.2. Global Gleevec Revenue and Market Share by Product (2017-2027)
5.2.1. Global Gleevec Revenue and Revenue Share by Product (2017-2027)
5.3. 100mg
5.3.1. Global 100mg Revenue and Growth Rate (2017-2027)
5.4. 400mg
5.4.1. Global 400mg Revenue and Growth Rate (2017-2027)
6. Gleevec Market, By End User
6.1. Introduction
6.2. Global Gleevec Revenue and Market Share by End User (2017-2027)
6.2.1. Global Gleevec Revenue and Revenue Share by End User (2017-2027)
6.3. Hospital
6.3.1. Global Hospital Revenue and Growth Rate (2017-2027)
6.4. Pharmacy
6.4.1. Global Pharmacy Revenue and Growth Rate (2017-2027)
7. Gleevec Market, By Region
7.1. Introduction
7.2. Global Gleevec Revenue and Market Share by Regions
7.2.1. Global Gleevec Revenue by Regions (2017-2027)
7.3. North America Gleevec by Countries
7.3.1. North America Gleevec Revenue and Growth Rate (2017-2027)
7.3.2. North America Gleevec Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Gleevec by Countries
7.4.1. Europe Gleevec Revenue and Growth Rate (2017-2027)
7.4.2. Europe Gleevec Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Gleevec by Countries
7.5.1. Asia-Pacific Gleevec Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Gleevec Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Gleevec by Countries
7.6.1. South America Gleevec Revenue and Growth Rate (2017-2027)
7.6.2. South America Gleevec Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Gleevec by Countries
7.7.1. Middle East and Africa Gleevec Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Gleevec Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Novartis
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
9. Gleevec Market Forecast (2017-2027)
9.1. Global Gleevec Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Gleevec Market Forecast by Regions (2017-2027)
9.2.1. North America Gleevec Market Forecast (2017-2027)
9.2.1.1. United States Gleevec Market Forecast (2017-2027)
9.2.1.2. Canada Gleevec Market Forecast (2017-2027)
9.2.1.3. Mexico Gleevec Market Forecast (2017-2027)
9.2.2. Europe Gleevec Market Forecast (2017-2027)
9.2.2.1. Germany Gleevec Market Forecast (2017-2027)
9.2.2.2. France Gleevec Market Forecast (2017-2027)
9.2.2.3. UK Gleevec Market Forecast (2017-2027)
9.2.2.4. Russia Gleevec Market Forecast (2017-2027)
9.2.2.5. Italy Gleevec Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Gleevec Market Forecast (2017-2027)
9.2.3. Asia-Pacific Gleevec Market Forecast (2017-2027)
9.2.3.1. China Gleevec Market Forecast (2017-2027)
9.2.3.2. Japan Gleevec Market Forecast (2017-2027)
9.2.3.3. Korea Gleevec Market Forecast (2017-2027)
9.2.3.4. India Gleevec Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Gleevec Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Gleevec Market Forecast (2017-2027)
9.2.4. South America Gleevec Market Forecast (2017-2027)
9.2.4.1. Brazil Gleevec Market Forecast (2017-2027)
9.2.4.2. Argentina Gleevec Market Forecast (2017-2027)
9.2.4.3. Columbia Gleevec Market Forecast (2017-2027)
9.2.4.4. Rest of South America Gleevec Market Forecast (2017-2027)
9.2.5. Middle East and Africa Gleevec Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Gleevec Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Gleevec Market Forecast (2017-2027)
9.2.5.3. Egypt Gleevec Market Forecast (2017-2027)
9.2.5.4. Nigeria Gleevec Market Forecast (2017-2027)
9.2.5.5. South Africa Gleevec Market Forecast (2017-2027)
9.2.5.6. Turkey Gleevec Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Gleevec Market Forecast (2017-2027)
9.3. Gleevec Market Forecast by Product (2017-2027)
9.3.1. Gleevec Forecast by Product (2017-2027)
9.3.2. Gleevec Market Share Forecast by Product (2017-2027)
9.4. Gleevec Market Forecast by End User (2017-2027)
9.4.1. Gleevec Forecast by End User (2017-2027)
9.4.2. Gleevec Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Gleevec Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Gleevec Revenue and Revenue Share by Product (2017-2018)
Figure Global 100mg Revenue and Growth Rate (2017-2018)
Figure Global 400mg Revenue and Growth Rate (2017-2018)
Table Global Gleevec Revenue and Revenue Share by End User (2017-2018)
Figure Global Hospital Revenue and Growth Rate (2017-2018)
Figure Global Pharmacy Revenue and Growth Rate (2017-2018)
Table Global Gleevec Revenue by Regions (2017-2018)
Figure North America Gleevec Growth Rate (2017-2018)
Figure North America Gleevec Revenue and Growth Rate (2017-2018)
Figure North America Gleevec by Countries (2017-2018)
Figure North America Gleevec Revenue (Million USD) by Countries (2017-2018)
Figure United States Gleevec Growth Rate (2017-2018)
Figure United States Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Gleevec Growth Rate (2017-2018)
Figure Canada Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Gleevec Growth Rate (2017-2018)
Figure Mexico Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Gleevec Growth Rate (2017-2018)
Figure Europe Gleevec Revenue and Growth Rate (2017-2018)
Figure Europe Gleevec by Countries (2017-2018)
Figure Europe Gleevec Revenue (Million USD) by Countries (2017-2018)
Figure Germany Gleevec Growth Rate (2017-2018)
Figure Germany Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Gleevec Growth Rate (2017-2018)
Figure France Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Gleevec Growth Rate (2017-2018)
Figure UK Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Gleevec Growth Rate (2017-2018)
Figure Russia Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Gleevec Growth Rate (2017-2018)
Figure Italy Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Gleevec Growth Rate (2017-2018)
Figure Rest of Europe Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Gleevec Growth Rate (2017-2018)
Figure Asia-Pacific Gleevec Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Gleevec by Countries (2017-2018)
Figure Asia-Pacific Gleevec Revenue (Million USD) by Countries (2017-2018)
Figure China Gleevec Growth Rate (2017-2018)
Figure China Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Gleevec Growth Rate (2017-2018)
Figure Japan Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Gleevec Growth Rate (2017-2018)
Figure Korea Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Gleevec Growth Rate (2017-2018)
Figure India Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Gleevec Growth Rate (2017-2018)
Figure Southeast Asia Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Gleevec Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Gleevec Growth Rate (2017-2018)
Figure South America Gleevec Revenue and Growth Rate (2017-2018)
Figure South America Gleevec by Countries (2017-2018)
Figure South America Gleevec Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Gleevec Growth Rate (2017-2018)
Figure Brazil Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Gleevec Growth Rate (2017-2018)
Figure Argentina Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Gleevec Growth Rate (2017-2018)
Figure Columbia Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Gleevec Growth Rate (2017-2018)
Figure Rest of South America Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Gleevec Growth Rate (2017-2018)
Figure Middle East and Africa Gleevec Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Gleevec by Countries (2017-2018)
Figure Middle East and Africa Gleevec Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Gleevec Growth Rate (2017-2018)
Figure Saudi Arabia Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Gleevec Growth Rate (2017-2018)
Figure United Arab Emirates Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Gleevec Growth Rate (2017-2018)
Figure Egypt Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Gleevec Growth Rate (2017-2018)
Figure Nigeria Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Gleevec Growth Rate (2017-2018)
Figure South Africa Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Gleevec Growth Rate (2017-2018)
Figure Turkey Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Gleevec Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Gleevec Revenue (Millions USD) and Growth Rate (2017-2018)
Table Novartis Gleevec Financial Overview
Figure Global Gleevec Revenue (Millions USD) and Growth Rate (2018-2025)
Table Gleevec Market Forecast by Regions (2018-2025)
Figure North America Gleevec Market Forecast (2018-2025)
Figure United States Gleevec Market Forecast (2018-2025)
Figure Canada Gleevec Market Forecast (2018-2025)
Figure Mexico Gleevec Market Forecast (2018-2025)
Figure Europe Gleevec Market Forecast (2018-2025)
Figure Germany Gleevec Market Forecast (2018-2025)
Figure France Gleevec Market Forecast (2018-2025)
Figure UK Gleevec Market Forecast (2018-2025)
Figure Russia Gleevec Market Forecast (2018-2025)
Figure Italy Gleevec Market Forecast (2018-2025)
Figure Rest of Europe Gleevec Market Forecast (2018-2025)
Figure Asia-Pacific Gleevec Market Forecast (2018-2025)
Figure China Gleevec Market Forecast (2018-2025)
Figure Japan Gleevec Market Forecast (2018-2025)
Figure Korea Gleevec Market Forecast (2018-2025)
Figure India Gleevec Market Forecast (2018-2025)
Figure Southeast Asia Gleevec Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Gleevec Market Forecast (2018-2025)
Figure South America Gleevec Market Forecast (2018-2025)
Figure Brazil Gleevec Market Forecast (2018-2025)
Figure Argentina Gleevec Market Forecast (2018-2025)
Figure Columbia Gleevec Market Forecast (2018-2025)
Figure Rest of South America Gleevec Market Forecast (2018-2025)
Figure Middle East and Africa Gleevec Market Forecast (2018-2025)
Figure Saudi Arabia Gleevec Market Forecast (2018-2025)
Figure United Arab Emirates Gleevec Market Forecast (2018-2025)
Figure Egypt Gleevec Market Forecast (2018-2025)
Figure Nigeria Gleevec Market Forecast (2018-2025)
Figure South Africa Gleevec Market Forecast (2018-2025)
Figure Turkey Gleevec Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Gleevec Market Forecast (2018-2025)
Figure Global Gleevec Forecast by Product (2018-2025)
Figure Global Gleevec Market Share Forecast by Product (2018-2025)
Figure Global Gleevec Forecast by Product (2018-2025)
Figure Global Gleevec Forecast by End User (2018-2025)
Figure Global Gleevec Market Share Forecast by End User (2018-2025)
Figure Global Gleevec Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|